Claudine Bruck
Director/Board Member at ANNOVIS BIO, INC.
Net worth: 78 147 $ as of 31/03/2024
Profile
Claudine E.
Bruck is the founder and currently holds the position of Chairman at Prolifagen LLC, which was founded in 2016.
She is also currently serving as an Independent Director at Annovis Bio, Inc. since 2015 and as the Chief Scientific Officer at SapVax LLC.
In her former positions, Dr. Bruck served as an Independent Director at Navidea Biopharmaceuticals, Inc. from 2018 to 2021.
She also held the position of Course Director at the University of Pennsylvania, Head-Cancer Vaccine Program at GlaxoSmithKline LLC, and Assistant Professor at Tufts University School of Medicine.
Dr. Bruck obtained a doctorate degree from Vrije Universiteit Brussel and a graduate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANNOVIS BIO INC
0.06% | 20/11/2023 | 6,567 ( 0.06% ) | 78 147 $ | 31/03/2024 |
Claudine Bruck active positions
| Companies | Position | Start |
|---|---|---|
| ANNOVIS BIO, INC. | Director/Board Member | 01/01/2015 |
| Prolifagen LLC | Founder | 01/06/2016 |
SapVax LLC
 SapVax LLC Pharmaceuticals: MajorHealth Technology SapVax LLC develops a platform for generating peptide-based, self-adjuvanting cancer vaccines. Its platform is based on a flexible synthetic method for linking tumor antigens with an adjuvant, which enables the generation of vaccines targeting virtually any peptide tumor antigen. The company was founded by Rod Dunbar and Margaret Brimble in 2016 and is headquartered in Cleveland, OH. | Chief Tech/Sci/R&D Officer | - |
Ophidion, Inc.
 Ophidion, Inc. BiotechnologyHealth Technology Ophidion, Inc. is an early-stage central nervous system biopharmaceutical company. The company was founded by Julie Miwa and is headquartered in Pasadena, CA. | Director/Board Member | - |
Former positions of Claudine Bruck
| Companies | Position | End |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Director/Board Member | 14/09/2021 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
| Tufts University School of Medicine | Corporate Officer/Principal | - |
Training of Claudine Bruck
| Vrije Universiteit Brussel | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| ANNOVIS BIO, INC. | Health Technology |
| Private companies | 4 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
SapVax LLC
SapVax LLC Pharmaceuticals: MajorHealth Technology SapVax LLC develops a platform for generating peptide-based, self-adjuvanting cancer vaccines. Its platform is based on a flexible synthetic method for linking tumor antigens with an adjuvant, which enables the generation of vaccines targeting virtually any peptide tumor antigen. The company was founded by Rod Dunbar and Margaret Brimble in 2016 and is headquartered in Cleveland, OH. | Health Technology |
| Prolifagen LLC | |
Ophidion, Inc.
Ophidion, Inc. BiotechnologyHealth Technology Ophidion, Inc. is an early-stage central nervous system biopharmaceutical company. The company was founded by Julie Miwa and is headquartered in Pasadena, CA. | Health Technology |
- Stock Market
- Insiders
- Claudine Bruck
